Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) EBT Margin (2016 - 2025)

Collegium Pharmaceutical (COLL) has 10 years of EBT Margin data on record, last reported at 233.41% in Q4 2025.

  • For Q4 2025, EBT Margin fell 24290.0% year-over-year to 233.41%; the TTM value through Dec 2025 reached 33.45%, up 1784.0%, while the annual FY2025 figure was 131.95%, 14756.0% down from the prior year.
  • EBT Margin reached 233.41% in Q4 2025 per COLL's latest filing, down from 199.55% in the prior quarter.
  • Across five years, EBT Margin topped out at 31.19% in Q4 2023 and bottomed at 233.41% in Q4 2025.
  • Average EBT Margin over 5 years is 21.66%, with a median of 9.27% recorded in 2024.
  • Peak YoY movement for EBT Margin: surged 13607bps in 2022, then crashed -24290bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 142.08% in 2021, then soared by 96bps to 6.01% in 2022, then surged by 619bps to 31.19% in 2023, then plummeted by -70bps to 9.49% in 2024, then crashed by -2559bps to 233.41% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 233.41% in Q4 2025, 199.55% in Q3 2025, and 9.06% in Q2 2025.